logo

MMSI

Merit Medical·NASDAQ
--
--(--)
--
--(--)
6.45 / 10
Outperform

Merit Medical shows adequate fundamentals with strengths in Profit-MV and Cash-MV, but faces issues in Revenue-MV and Asset-MV. The fundamental score of 6.5/10 and positive cash-flow-to-revenue ratio of 17.7% indicate solid operational health, while ROA at 3.58% and net profit margin on assets at 4.78% support profitability. However, negative Revenue-MV and Asset-MV suggest room for growth in scale and asset efficiency.

Fundamental(6.45)SentimentTechnical

Analysis Checks(8/10)

Revenue-MV
Value-0.36
Score1/3
Weight-8.72%
1M Return-1.58%
ROA (%)
Value3.58
Score3/3
Weight5.33%
1M Return0.81%
Net cash flow from operating activities / Operating revenue (%)
Value17.72
Score3/3
Weight7.06%
1M Return1.03%
Profit-MV
Value-0.09
Score2/3
Weight20.59%
1M Return2.92%
Net income-Revenue
Value-0.61
Score2/3
Weight-12.83%
1M Return-2.32%
Cash-UP
Value-0.36
Score3/3
Weight40.45%
1M Return5.34%
Annualized net profit margin on total assets (%)
Value4.78
Score3/3
Weight5.33%
1M Return0.81%
Asset-MV
Value-0.51
Score1/3
Weight2.17%
1M Return0.36%
Cash-MV
Value-0.51
Score2/3
Weight35.62%
1M Return4.51%
Net profit / Total profit (%)
Value75.48
Score3/3
Weight4.99%
1M Return0.77%
Is MMSI undervalued or overvalued?
  • MMSI scores 6.45/10 on fundamentals and holds a Discounted valuation at present. Backed by its 6.22% ROE, 8.02% net margin, 41.30 P/E ratio, 3.20 P/B ratio, and -2.90% earnings growth, these metrics solidify its Outperform investment rating.